Veralto

Veralto has signed a definitive agreement to buy Cleanwater1 for $465 million (net about $452 million after tax benefits). Cleanwater1 provides on-site hypochlorite disinfection, solids management and odor filtration and operates roughly 25,000 sites; trailing 12‑month revenue to June 30, 2026 was about $135 million, roughly 25% of which is aftermarket. The purchase price equals about 17 times adjusted EBITDA; closing is expected in Q4 2026, and Veralto expects a neutral to slightly positive effect on adjusted EPS in 2027 and a return on invested capital in line with or above its cost of capital by the fourth year. » More on de.investing.com

Veralto issued a $725 million senior note with a coupon of 4.850% and an issue price of 99.996%. Closing is expected around June 1, 2026, and interest will be paid semiannually. Net proceeds are estimated at about $720.6 million and will be used for general corporate purposes, including refinancing existing indebtedness; BofA, Citigroup and J.P. Morgan are acting as joint book-running managers. » More on de.investing.com

Veralto shares recently fell to a 52-week low of $84.97, about 15% below their level a year ago. The stock trades at a P/E ratio of 22.73, and analysts have recently cut their earnings estimates (12 cuts according to InvestingPro). At the same time, Veralto beat Q1 expectations with EPS of $1.07 and raised its full-year guidance to $4.20–$4.28; BMO raised its price target to $110 and the board approved a quarterly cash dividend of $0.13. » More on de.investing.com

Veralto reported Q1 2026 EPS of $1.07 versus $0.88 expected, up 21.6%, and revenue of $1.42bn (+7% year-over-year). Adjusted EPS rose 13% and the stock gained 5.15% in premarket trading to $90.01. The company raised its full-year EPS forecast to $4.20–4.28 and cited strategic acquisitions and share buybacks to strengthen its market position. Challenges remain, including one-off effects in the PQI segment and potential cost pressure from tariffs, oil prices and regional risks, particularly in China. » More on de.investing.com

Veralto has completed the acquisition of GlobalVision and is integrating the AI-powered quality and compliance tool into its Esko division. GlobalVision most recently posted an expected 2026 revenue run rate of around USD 25m, with roughly 85% recurring revenue and an adjusted EBITDA margin of about 30%. The purchase price equals roughly 15 times the estimated adjusted EBITDA of USD 13m; the transaction is expected to be EPS-neutral in 2026 and accretive from 2027. In addition, Veralto repurchased about 3.2m common shares for roughly USD 300m in Q1 2026. » More on de.investing.com